Drug Database
CL

clobetasol (DFD06 / DFD06 Cream / DFD 06)

✓ Approved

Encore Dermatology, Inc. · NR3C1 · Steroids

What is clobetasol?

clobetasol is a steroids developed by Encore Dermatology, Inc.. It is approved for therapeutic indications via topical.

Drug Profile

Brand NamesDFD06, DFD06 Cream, DFD 06
CompanyEncore Dermatology, Inc.
Drug ClassSteroids, Small Molecule
Molecular TargetNR3C1
RouteTopical
StatusApproved

Mechanism of Action

Molecular Targets

clobetasol acts on 1 molecular target:

NR3C1nuclear receptor subfamily 3 group C member 1 (GR, GCCR)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

clobetasol is developed for 1 unique indication across 1 therapeutic area.

Therapeutic AreaConditionPhase
Skin and subcutaneous tissue disordersPsoriasis✓ Approved

Related Research Articles

PubMedInternational journal of retina and vitreous2026-09-19

Microaneurysm segmentation in early diabetic retinopathy: a localized patch-based U-Net approach to overcome microscopic lesion oversight.

Atada Likhitha D LD, Manjunath Madhura Prakash MP, Prasad Deepthi K DK, Srinivasan Venkatakrishnan V

Diabetic Retinopathy (DR) is a leading cause of vision impairment and a major long-term microvascular complication of diabetes. Early detection and prevention of diabetes-related complications through advanced imaging and software-assisted patient management remain important clinical priorities. Microaneurysms (MAs) are the earliest and most subtle indicators of DR, but their small size and low contrast often lead to missed detection during manual fundus examination, delaying intervention. Automated MA segmentation is therefore essential for large-scale DR screening. We conducted a controlled empirical evaluation of localized patch-based training for microaneurysm (MA) segmentation, benchmarking a compact, imbalance-aware U-Net model including learnable transposed-convolution up-sampling against a full-image U-Net trained on identical data. Fundus images and corresponding MA masks were divided into non-overlapping 256 × 256 patches, increasing MA pixel density per training sample by approximately 60-fold relative to full-image input thereby directly targeting the extreme class imbalance that causes full-image models to collapse to all-background predictions. The model was trained and evaluated on the publicly available IDRiD [Indian Diabetic Retinopathy Image Dataset] and DDR [Dataset for Diabetic Retinopathy] datasets. Performance was assessed using Intersection over Union (IoU), Dice coefficient, accuracy, recall, and precision. Performance was evaluated on a representative held-out subset of 100 images selected from an independent pool of 514 MA-annotated test images spanning the IDRiD and DDR datasets. The patch-based model achieved an overall pixel-level accuracy of 99.89%, a Dice coefficient of 76.9%, IoU of 63.2%, recall (sensitivity) of 69.1% and precision of 88.7%, while the full-image U-Net trained on the same data failed to recover any MA pixels (IoU = 0, Dice = 0) despite comparable pixel accuracy thereby demonstrating that overlap-based metrics, not accuracy, are the decisive criterion for this task. Per-image lesion-coverage analysis showed a mean match rate of approximately 60% of annotated MA contours, providing a clinically interpretable read-out beyond pixel overlap. This controlled empirical evaluation demonstrates that localized patch-based training is an effective and computationally efficient strategy for overcoming the extreme class imbalance that causes conventional full-image U-Nets to systematically miss microaneurysms. The proposed patch-based U-Net showed promising microaneurysm segmentation performance on a held-out subset of IDRiD and DDR images; further evaluation on the additional datasets and independent external cohorts can aid in the clinical screening utility.

PubMedSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society2026-09-18

The impact of type 2 diabetes mellitus on anterior segment parameters.

Ocal Huzeyfe H, Erol Yasemin O YO, Kazanci Burcu B, Soba Dilek O DO et al.

The purpose of this study was to investigate the impact of type 2 diabetes mellitus (DM) on anterior segment parameters. A total of 90 patients with DM and 30 control subjects were included, and patients were divided into three groups (n = 30 for each) based on the presence and type of diabetic retinopathy (DR) including those with no DR (NDR), those with nonproliferative DR (NPDR), and those with proliferative DR (PDR). Anterior segment parameters obtained with a Pentacam HR device were compared between study groups as well as according to the duration of diabetes and glycated hemoglobin level. In the NPDR, there was a statistically significant increase in the zone 3 lens density (LD) compared to the control and NDR (P = 0.030 and P = 0046, respectively). The anterior chamber volume was significantly lower in the PDR than in the NPDR (P = 0010). Anterior chamber depth was significantly lower in the PDR than in the control (P = 0023). Diabetes duration of ≥20 years was associated with a significantly higher zone 3 lens densitometry value compared to diabetes duration of <10 years (P = 0037). The detection of increased LD and other anterior segment changes in diabetic eyes using Pentacam may be an indicator in these patients that diabetes regulation should be controlled, even in the absence of clinical cataract development. It is noteworthy that the effects of DM on the anterior segment are not parallel to the effects on the retina.

PubMedFrontiers in endocrinology2026-09-18

Development and validation of an explainable machine learning model for differentiating diabetic nephropathy from diabetic retinopathy in patients with type 2 diabetes.

Zhang Yonglin Y, Feng Siyu S, Xue Yukun Y, Xue Li L et al.

Diabetic nephropathy (DN) and diabetic retinopathy (DR) are common microvascular complications of type 2 diabetes mellitus (T2DM) and may require different diagnostic and management pathways. This study aimed to develop and validate an interpretable machine learning model based on routine laboratory data to differentiate prevalent DN from prevalent DR among hospitalized patients with type 2 diabetes. Data were collected from a large tertiary hospital in China and split into a training/internal validation cohort (DN: 2,309 cases; DR: 855 cases) and an independent held-out validation cohort (DN: 578 cases; DR: 214 cases). A total of 47 routinely available laboratory and demographic variables were extracted from electronic health records (EHRs). Seven machine learning algorithms were developed and compared, with recursive feature elimination (RFE) employed to identify the most informative subset of features and enhance model performance and interpretability. Model discrimination was assessed using the area under the receiver operating characteristic curve (AUC) and the area under the precision-recall curve (AP), while SHAP values were used to interpret feature importance and explain individual-level predictions. The extreme gradient boosting (XGBoost) classifier demonstrated the highest predictive performance among the seven machine learning algorithms evaluated. After selecting the top five features based on importance rankings, an explainable XGBoost model was constructed. This final model achieved strong apparent discrimination in both the training/internal validation cohort (AUC = 0.991, 95% CI: 0.989-0.994; AP = 0.979, 95% CI: 0.973-0.984) and the held-out validation cohort (AUC = 0.997, 95% CI: 0.996-0.999; AP = 0.993, 95% CI: 0.988-0.997). SHAP analysis further identified α-hydroxybutyrate dehydrogenase, creatine kinase-MB, creatinine, urinary α1-microglobulin, and N-acetyl-β-D-glucosaminidase as the most influential features contributing to complication risk prediction. An explainable machine learning model for predicting complications in patients with T2DM demonstrated high feasibility and effectiveness, indicating strong potential to support clinical management and improve patient outcomes. By incorporating SHAP analyses, the model addresses key concerns regarding transparency and clinical decision-making. These findings highlight the model's potential for real-world clinical implementation.

PubMedIn vitro cellular & developmental biology. Animal2026-09-18

Huwang Mingmu decoction protects retinal neurons in early diabetic retinopathy by suppressing the IL-1β-c-Jun-GS pathway: an in vivo and in vitro study.

Qin Xuewei X, Wang Limin L, Yao Xianfeng X, Chen Mei M et al.

Huwang Mingmu decoction (HWMMT) is a traditional Chinese herbal formula used clinically for diabetic retinopathy (DR), but its neuroprotective mechanisms remain unclear. This study aimed to investigate whether HWMMT protects retinal neurons in early DR by attenuating glutamate excitotoxicity via the IL-1β/c-Jun/glutamine synthetase (GS) signaling axis. Diabetes was induced in Sprague-Dawley rats by streptozotocin injection, and animals were randomized into control, diabetic model (DM), and HWMMT-treated diabetic (DM + HWMMT) groups. HWMMT was orally administered for 8 wk, with body weight and blood glucose monitored weekly. At weeks 4 and 8, retinal tissues and serum were collected for qRT-PCR, Western blotting, and ELISA. In vitro, primary rat retinal Müller glial cells (Müller) were cultured and assigned to five groups: blank control, HWMMT serum control, high-glucose (HG), HG + HWMMT, and HG + HWMMT + IL-1β (rescue group). Cell viability, LDH release, glutamate secretion, apoptosis, and expression of IL-1β, c-Jun, and GS were evaluated. In vivo, DM rats showed slower weight gain, sustained hyperglycemia, upregulated retinal IL-1β and c-Jun expression, downregulated GS, and elevated serum glutamate; HWMMT treatment significantly reversed these abnormalities. In vitro, HG exposure decreased Müller cell viability, increased apoptosis, LDH leakage and glutamate release, and induced IL-1β/c-Jun upregulation with GS downregulation; co-treatment with HWMMT-containing serum reversed all these changes. Notably, exogenous IL-1β supplementation significantly attenuated the cytoprotective and anti‑apoptotic effects of HWMMT and reversed its modulation of IL-1β, c-Jun, GS, and glutamate homeostasis. Collectively, these findings demonstrate that HWMMT exerts neuroprotection in early DR by suppressing the IL-1β/c-Jun signaling cascade and restoring GS expression and function in Müller cells, thereby reducing extracellular glutamate accumulation and mitigating excitotoxic damage. The rescue experiments further support that HWMMT acts specifically through this pathway, providing mechanistic insight and preclinical evidence for HWMMT as a potential therapeutic intervention for early diabetic retinopathy.

PubMedJournal of epidemiology and population health2026-09-18

Algorithms for the identification of ophthalmic diseases in medico-administrative databases: A systematic review.

Neau Julie J, Turpin Agathe A, Rajendrabose Deivanes D, Haneef Romana R et al.

Medico-administrative databases (MADs) are increasingly used in comparative effectiveness research. To conduct a systematic review of algorithms used for the identification of key ophthalmic diseases in MADs: age-related macular degeneration (AMD), diabetic retinopathy (DR)/ diabetic macular edema (DME), glaucoma, cataract and uveitis. We searched PubMed between June 30, 2016, and August 6, 2024, using keywords related to MADs and the ophthalmic diseases of interest. Two reviewers independently selected studies and extracted data. From the 1719 references identified, 315 were selected describing a total of 523 algorithms. Approximately half of the study objectives were related to the identification of factors associated with the onset of ophthalmic diseases, exacerbation, or hospitalization (48%, n = 151). Only 2% (n = 6) focused exclusively on the development and/or validation of algorithms. Most studies were from Taiwan (36%, n = 113), Korea (27%, n = 84) and the United States (20%, n = 64). From the 523 algorithms, a validation was mentioned for 47 (9%). After regrouping close algorithms, 433 different algorithms were identified concerning glaucoma (34%, n = 146), DR/DME (26%, n = 114), AMD (18%, n = 80), cataract (11%, n = 47) and uveitis (11%, n = 46). About half of these algorithms used diagnosis codes only (58%, n = 251), while others combined diagnosis codes and procedures (16%, n = 69), or diagnosis codes and drugs (12%, n = 50). This systematic review showed heterogeneity between algorithms used to identify the same pathology, raising the question of which ones are more appropriate to use in a particular context. Moreover, most algorithms were not validated despite the potential impact on study results.

PubMedJournal of vitreoretinal diseases2026-09-18

Baseline and 3-Year Follow-Up Changes in Retinal Neurovascular Structures Assessed by OCT and OCTA in Pediatric Type 1 Diabetes Without Retinopathy.

Tiryaki Demir Semra S, Uçar Ahmet A, Akbaş Özyürek Emine Betül EB, Çakır Ecrin E et al.

To investigate longitudinal changes in retinal neurovascular components over a 3-year period using optical coherence tomography (OCT) and OCT angiography (OCTA) in pediatric and adolescent individuals diagnosed with type 1 diabetes mellitus (DM) but without signs of diabetic retinopathy (DR). Individuals with type 1 DM and no clinical signs of DR were evaluated between May and September 2022. Quantitative evaluation was performed on neurovascular components of the retina in both the macular and peripapillary regions. Data from the previous 3 years (Group 1) were compared with current data (Group 2). Relationships between pubertal stage, duration of diabetes, and glycosylated hemoglobin (HbA1c) levels were examined. The study included 92 eyes from 46 participants diagnosed with type 1 DM. Group 2 had significantly lower vessel densities in the foveal and parafoveal superficial capillary plexus and deep capillary plexus than Group 1. However, central foveal thickness (CFT), inner retinal thickness, peripapillary retinal nerve fiber layer thickness, and nasal inferior disc-vessel density were significantly higher in Group 2. A significant relationship was found between pubertal stage and vessel densities in both the superficial capillary plexus and optic disc regions. HbA1c levels and diabetes duration correlated with the foveal avascular zone area and superficial capillary plexus/deep capillary plexus-vessel densities. Initially, the peripapillary microvascular structure is more affected than the macula in type 1 DM. However, after 3 years, microvascular macular decline becomes more prominent. Additionally, foveal retinal thickness and peripapillary retinal nerve fiber layer thickness were significantly increased.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about clobetasol